William Pao is a physician-scientist whose career has spanned academia, industry and biotech. He started his career as a thoracic oncologist, lab researcher and clinical investigator at Memorial Sloan-Kettering Cancer Center in New York and then Vanderbilt University in Nashville, where he also served as the Division Chief of Haematology/Oncology. Through executive leadership positions at Roche and Pfizer, he oversaw the discovery and development of portfolios of new molecular entities, many of which have been approved, to treat a variety of diseases. He currently is CEO and Co-Founder of a cancer biotechnology company.
Meet the doctors, scientists, patients and campaigners tackling the world’s worst diseases We often hear about the dark side of the pharmaceutical industry – from extortionate pricing to the opioid epidemic. But there’s another story to be told. Through the story of eight revolutionary...
Más información
